Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2024BrainOpen Access

Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

View Full Paper
Ask AI
Bookmark
Share

Authors

AWAna WestenbergerVSVolha SkrahinaTUTatiana Usnich

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Westenberger et al. (2024) studied this question.

synapsesocial.com/papers/68e5dc44b6db64358757173bhttps://doi.org/10.1093/brain/awae188
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1GBA p.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis2016 · 101 citations
  2. 2Low clinical diagnostic accuracy of early vs advanced Parkinson disease2014 · 512 citations
  3. 3Genetic analysis of Mendelian mutations in a large UK population-based Parkinson’s disease study2019 · 81 citations
  4. 4Diagnostic exome sequencing in early‐onset Parkinson's disease confirms <i>VPS13C</i> as a rare cause of autosomal‐recessive Parkinson's disease2017 · 98 citations
  5. 5Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding2022 · 147 citations